Inside Amrutam's Journey from Ayurvedic Manufacturer to Consumer Brand

In Ayurveda, almost every brand promises authenticity. Few can prove it.

Consumers cannot easily verify the quality of herbs, the purity of ingredients or the consistency of manufacturing. That leaves them relying on trust as much as science. For Amrutam, a bootstrapped Ayurvedic wellness brand, that uncertainty has become the centre of its business strategy. Rather than competing solely on advertising or celebrity endorsements, the company claims its advantage lies in controlling manufacturing, narrowing its focus to women's health and letting customer advocacy do much of the marketing.

Official filings tell only part of the story. According to Tofler, revenue from operations rose to ₹2.99 crore in FY22 from ₹2.55 crore in FY21, while the company reported a net loss of ₹44 lakh against a net profit of ₹1.5 lakh the previous year. Those remain the latest publicly available statutory financials. The company has not filed its financial statements with the Registrar of Companies for the past three financial years, making it difficult to independently verify its more recent financial performance.

Co-founder Stuti Ashok Gupta claims annual revenue now stands at around ₹50 crore. Internal dashboards shared with OPEN purport to show total sales of ₹35.65 crore across 299,239 orders between July 2025 and June 2026, including ₹8.54 crore from Amazon.

In Ayurveda market, independent verification is often limited. According to N. Chandramouli, CEO of TRA Research, advertising may create awareness, but trust in Ayurveda is built through deeper signals such as sourcing, formulation discipline, manufacturing quality, consistency and consumer experience.

That philosophy is central to how Amrutam wants to position itself.

A factory before a brand

Amrutam's origins lie in manufacturing rather than consumer branding.

Founder Ashok Gupta entered Ayurvedic medicine distribution in the 1990s before setting up a manufacturing business in 2006. When his daughter Stuti Gupta and son Agnim joined the business, they inherited production capabilities but little consumer recognition. Around 2019, the family began repositioning Amrutam as a direct-to-consumer brand.

Gupta claims the company owns its manufacturing facility, allowing it to oversee production from formulation to finished products rather than relying on third-party manufacturers.

That manufacturing-first approach is increasingly relevant, says Chandramouli. Unlike many consumer categories where branding can compensate for product similarity, Ayurveda demands consistency over long periods. Responsible manufacturing, transparent communication and disciplined formulation become part of the trust equation rather than merely operational decisions.

The company eventually narrowed its focus to women's health after several years of operating as a broader healthcare brand.

"The problem we are trying to solve is women's health," Gupta says. "Nobody is really deeply talking about what it's like when you get your period for the first time, or what the menopausal journey looks like."

Today, Amrutam's products are positioned around different life stages, with its traditional Ayurvedic malt forming the centrepiece of its portfolio. Gupta claims the products are designed around nourishment rather than quick symptom relief, drawing on classical Ayurvedic concepts such as Saptadhatu, or the body's seven tissue systems.

Marketing without looking like marketing

Despite spending roughly 30% of revenue on marketing, Gupta says the company's strongest-performing advertisements are often unpaid customer videos.

"Our top-performing ads today are videos made by customers we haven't paid," she says. "They picked up their phone, made a low-production video and sent it to us."

That reflects a wider shift in how trust is created.

Chandramouli argues that customer advocacy forms the second layer of credibility after product quality. "If people repeatedly experience benefit and speak about it voluntarily, it gives the brand a credibility that paid communication alone cannot create. Marketing can amplify trust, but it cannot substitute it."

Amrutam's content strategy therefore extends beyond product promotion into broader conversations around digestion, spirituality and wellness. Gupta says the objective has always been to build the brand itself as a trusted voice rather than relying solely on influencers.

The company also works with micro-influencers, but Gupta claims unpaid customer testimonials have proved more persuasive because they appear more authentic than polished advertising.

The quality question

Gupta is also critical of practices she believes are common across the industry.

She claims some manufacturers substitute lower-grade ingredients while continuing to market products under familiar Ayurvedic names. As one example, she alleges that some brands use ashwagandha leaves instead of roots, despite differences in active compounds.

Gupta also states Amrutam sources ingredients directly from farmers and tribal communities with whom the family has worked for more than two decades and that the company does not manufacture white-label products.

Whether consumers can distinguish between these practices remains uncertain. But Chandramouli argues that brands which consistently combine authentic formulations, disciplined manufacturing and transparent communication are more likely to earn long-term credibility than those relying primarily on advertising.

Scaling carefully

Unlike many venture-backed wellness brands, Amrutam says it has remained bootstrapped and profitable. Gupta says the company deliberately postponed raising outside capital until it had built stronger operational capabilities.

She claims demand is currently outpacing production capacity, making manufacturing expansion a more immediate priority than entering quick commerce. The company also says it wants to keep its own website as its primary sales channel rather than chasing rapid distribution growth.

Asked whether Amrutam could eventually be acquired, Gupta says the answer is "most likely no" for now, citing concerns over preserving the company's manufacturing philosophy and organisational culture.

Whether that approach ultimately produces a larger business remains to be seen. But it reflects a wider debate unfolding across India's Ayurveda industry.

"The Ayurveda brands that will endure are likely to be those that combine authentic formulation, responsible manufacturing, transparent communication and strong consumer word-of-mouth," Chandramouli says. "Scale may make a brand visible, but trust is built only when the product experience consistently validates the promise."

For brands operating in a category where consumers often cannot verify quality for themselves, that may prove to be the hardest promise of all.